Ocaliva 10 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FWFCE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,320
Award facts
- Contract value 100% obligated
- $10,320.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Ocaliva 10 mg tablets in quantities of 30 units. This firm fixed-price delivery order carries a ceiling value of $10,320.10 and is scheduled for completion by September 2, 2025. The award utilized no set-aside designation, allowing the vendor to compete directly in the open market. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a single-award vehicle valued at approximately $500 million and valid through November 2026.
The IDC serves as the primary mechanism through which the DLA issues delivery orders for pharmaceutical products supporting military health facilities worldwide. DMS Pharmaceutical Group's portfolio encompasses a comprehensive range of pharmaceutical items, including prescription medications, biologics, over-the-counter products, and medical consumables across multiple delivery formats. The company's established position as a critical supplier within the federal pharmaceutical supply chain reflects its consistent ability to meet the Department of Defense's healthcare logistics requirements across its extensive network of medical facilities.
Quick answers
Who was awarded contract SPE2DB25FWFCE?
SPE2DB25FWFCE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FWFCE worth?
The government has obligated $10,320 on SPE2DB25FWFCE.
Is contract SPE2DB25FWFCE an order under another contract?
Yes. SPE2DB25FWFCE is a delivery order under SPE2DB25D9320, an indefinite delivery contract.
Was contract SPE2DB25FWFCE competed?
The extent of competition for SPE2DB25FWFCE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award